TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.

NCT00741169 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
HCV
Tuberculosis
Rifampin
Pharmacokinetics

Interventions

DRUG: TMC435350
DRUG: Rifampin
DRUG: TMC435350+rifampin

Sponsor

Tibotec Pharmaceuticals, Ireland